Compare · FMS vs PARK
FMS vs PARK
Side-by-side comparison of Fresenius Medical Care AG (FMS) and Park Dental Partners Inc. (PARK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both FMS and PARK operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- FMS is the larger of the two at $12.31B, about 103.5x PARK ($118.9M).
- Both names hit the wire about 8 times in the past 4 weeks.
- FMS has more recent analyst coverage (25 ratings vs 2 for PARK).
- Company
- Fresenius Medical Care AG
- Park Dental Partners Inc.
- Price
- -
- -
- Market cap
- $12.31B
- $118.9M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 8
- 8
- Recent ratings
- 25
- 2
Fresenius Medical Care AG
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Latest FMS
- Amendment: SEC Form SCHEDULE 13D/A filed by Fresenius Medical Care AG
- SEC Form 6-K filed by Fresenius Medical Care AG
- Fresenius Medical downgraded by Barclays
- SEC Form 6-K filed by Fresenius Medical Care AG
- SEC Form 6-K filed by Fresenius Medical Care AG
- Fresenius Medical Care reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook
- Fresenius Medical Care Brings Kidney Care Innovation to Critical Care Patients with U.S. Launch of multiFiltratePRO™
- Fresenius Medical Care presents new evidence and innovations advancing kidney care at ASN Kidney Week 2026
- SEC Form 6-K filed by Fresenius Medical Care AG
- Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth
Latest PARK
- Amendment: Park Dental Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- CORRECTION -- Park Dental Partners Announces Third Quarter 2026 Results
- SEC Form 10-Q filed by Park Dental Partners Inc.
- Park Dental Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Park Dental Partners Announces Third Quarter 2026 Results
- Park Dental Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- Park Dental Partners Completes Acquisition of Village Family Dental Support Services Organization, Expands into North Carolina
- Park Dental Partners Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Park Dental Partners Inc.
- SEC Form 8-K filed by Park Dental Partners Inc.